Clene Says Lead Drug Candidate Shows Potential to Treat Rett Syndrome
Clene Says Lead Drug Candidate Shows Potential to Treat Rett Syndrome
Clene稱其主要治療藥物候選品顯示出治療Rett綜合症的潛力
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊